US › Healthcare

Azitra Inc (AZTR)

US · Healthcare · Biotechnology

$0.18+9.61%

Last close · 2026-09-17

Latest quarter · ended 2026-06-30

Revenue

Net profit

$-3.3M

EPS

$-0.17

EPS estimate

$-0.21

EPS came in at -0.17 against a street estimate of -0.21 — a beat of 19.0%.

Key statistics

Market cap

$10.4M

P/E

8.6

Forward P/E

0.0

P/B

1.45

Book value

$0.12

EPS (TTM)

$0.02

52-week high

$0.80

52-week low

$0.10

50-day MA

$0.15

200-day MA

$0.22

Beta

-1.07

Analyst view

Analysts rate Azitra Inc a buy (1 buy, 0 hold, 0 sell out of 1) with an average price target of $0.78.

Shareholding

Insiders

7.59%

Institutions

32.04%

See the full picture

Technicals, trade setups with a published hit rate, AI analysis and earnings-call summaries for Azitra Inc — free to start.

Google Play App Store

Other Healthcare companies

Eli Lilly and Company Johnson & Johnson AbbVie Inc Merck & Company Inc UnitedHealth Group Incorporated Novartis AG ADR AstraZeneca PLC Thermo Fisher Scientific Inc Amgen Inc Novo Nordisk A/S Gilead Sciences Inc Abbott Laboratories

Data updated 2026-09-18.